OCC 1.23% 40.0¢ orthocell limited

Ann: Successful OrthoATI clinical trial, page-27

  1. 763 Posts.
    lightbulb Created with Sketch. 141
    No update for OrthoATI - rotator cuff since last year. Management have been cutting 'n pasting the same paragraph for 1 year now.
    Surely, they can give us an update for the "pathway to commercialisation" by now.
    What is the progress for the Phase IIb Randomised Control study?

    Great results today and hopefully OrthoATI- lateral epicondylitis can piggyback onto OrthoATI - rotator cuff which looks like it is about 1 year ahead, research/approval-wise.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.